Standard and perspectives for systemic treatments in stage 3?

Date 09 September 2017
Event ESMO 2017 Congress
Session ESMO-ESTRO: Lung cancer: Recent development of multimodal treatments
Topics Cytotoxic agents
Thoracic malignancies
Non-small-cell lung cancer
Biological therapy
Presenter Pilar Garrido Lopez
Authors P. Garrido Lopez
  • Medical Oncology, Hospital Universitario Ramon y Cajal, 28031 - Madrid/ES